Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Cambridge Cognition Holdings Plc

Healthcare GB COG

41.0GBX
0.50(1.23%)

Last update at 2026-03-10T13:54:00Z

Day Range

40.0041.00
LowHigh

52 Week Range

23.9045.00
LowHigh

Fundamentals

  • Previous Close 40.50
  • Market Cap19.79M
  • Volume23440
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.56300M
  • Revenue TTM9.05M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 7.25M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.70900M -3.45700M -0.62400M 0.25M -0.64900M
Minority interest - - - - -
Net income -1.78500M -3.50800M -0.40900M 0.45M -0.43800M
Selling general administrative 4.93M 6.14M 9.62M 7.83M 6.09M
Selling and marketing expenses 2.30M 2.98M - - -
Gross profit 8.39M 10.80M 9.32M 8.08M 5.42M
Reconciled depreciation 0.62M 0.67M 0.09M 0.15M 0.14M
Ebit -1.16200M -3.28900M -0.13800M 0.26M -0.64400M
Ebitda -0.54200M -2.62400M -0.03500M 0.41M -0.50200M
Depreciation and amortization 0.62M 0.67M 0.10M 0.15M 0.14M
Non operating income net other - - - - -
Operating income -1.16700M -3.30500M -0.13800M 0.26M -0.64400M
Other operating expenses 11.51M 16.82M 12.75M 9.83M 7.38M
Interest expense 0.56M 0.17M 0.02M 0.01M 0.00900M
Tax provision 0.08M 0.05M -0.21500M -0.19700M -0.21100M
Interest income 0.02M 0.02M 0.00900M 0.00000M 0.00400M
Net interest income -0.54200M -0.15200M -0.00700M -0.01100M -0.00500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.08M 0.05M -0.21500M -0.19700M -0.21100M
Total revenue 10.34M 13.52M 12.61M 10.09M 6.74M
Total operating expenses 9.55M 14.10M 9.46M 7.82M 6.06M
Cost of revenue 1.96M 2.72M 3.29M 2.02M 1.32M
Total other income expense net -0.54200M -0.15200M -0.48600M -0.01100M -0.00500M
Discontinued operations - - - - -
Net income from continuing ops -1.78500M -3.50800M -0.40900M 0.45M -0.43800M
Net income applicable to common shares - - - 0.45M -0.43800M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 13.03M 14.23M 15.11M 12.54M 6.26M
Intangible assets 3.33M 4.09M 0.94M 0.02M 0.03M
Earning assets - - - - -
Other current assets 1.01M 1.21M - 5.13M 2.65M
Total liab 9.67M 12.95M 15.01M 11.91M 6.21M
Total stockholder equity 3.36M 1.28M 0.10M 0.63M 0.06M
Deferred long term liab - - - - -
Other current liab 6.65M 1.98M -0.01800M -0.01800M -0.09800M
Common stock 0.42M 0.35M 0.31M 0.31M 0.31M
Capital stock 0.42M 0.35M 0.31M 0.31M 0.31M
Retained earnings -19.83200M -19.77800M -17.12000M -16.87800M -17.43900M
Other liab - - - - -
Good will 3.45M 3.65M 0.48M 0.35M 0.35M
Other assets - - - - -
Cash 1.29M 3.22M 8.32M 6.81M 3.05M
Cash and equivalents - - - - -
Total current liabilities 8.76M 10.97M 15.01M 11.91M 6.21M
Current deferred revenue - 7.70M - - -
Net debt 0.61M -0.66000M -8.30400M -6.79200M -2.94900M
Short term debt 1.00M 0.58M 0.02M 0.02M 0.10M
Short long term debt 0.98M 0.57M - - -
Short long term debt total 1.91M 2.56M 0.02M 0.02M 0.10M
Other stockholder equity 17.57M 15.10M 16.90M 17.20M 17.18M
Property plant equipment - - - 0.05M 0.14M
Total current assets 4.34M 6.18M 13.45M 12.07M 5.75M
Long term investments - - - - -
Net tangible assets - - - 0.26M -0.32200M
Short term investments 0.00600M 0.00600M - - -
Net receivables 1.91M 1.55M 4.68M 5.13M 2.10M
Long term debt 0.91M 1.98M - - -
Inventory 0.13M 0.19M 0.22M 0.13M 0.05M
Accounts payable 0.85M 0.60M 15.01M 11.91M 6.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 5.21M 5.61M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 0.31M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.02M 0.02M 0.05M 0.05M -
Deferred long term asset charges - - - - -
Non current assets total 8.69M 8.05M 1.66M 0.47M 0.52M
Capital lease obligations 0.02M 0.02M 0.02M 0.02M 0.10M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.05M -3.01900M -0.18000M -0.10500M -0.03800M
Change to liabilities - - - 5.78M 2.24M
Total cashflows from investing activities 0.05M -3.01900M - -0.10500M -0.03800M
Net borrowings -0.54700M 2.94M - -0.08600M -0.11300M
Total cash from financing activities 1.12M 2.88M -0.13200M -0.09700M 1.17M
Change to operating activities - - - - -
Net income -1.70900M -3.50800M -0.62400M 0.25M -0.64900M
Change in cash -1.92700M -5.10000M 1.51M 3.76M 2.15M
Begin period cash flow 3.22M 8.32M 6.81M 3.05M 0.90M
End period cash flow 1.29M 3.22M 8.32M 6.81M 3.05M
Total cash from operating activities -3.08500M -4.96700M 1.67M 3.94M 1.01M
Issuance of capital stock 2.68M 0.06M 0.00100M 0.00000M 1.40M
Depreciation 0.62M 0.67M 0.09M 0.15M 0.14M
Other cashflows from investing activities 0.05M 0.02M - - 0.00400M
Dividends paid - - - - -
Change to inventory 0.06M 0.03M -0.08800M -0.07500M 0.00200M
Change to account receivables -0.21000M 2.23M - -2.48200M -1.01000M
Sale purchase of stock - - - - -
Other cashflows from financing activities -1.00900M -0.10900M -0.18000M -0.10500M -0.23500M
Change to netincome - - - 0.12M 0.07M
Capital expenditures 0.00300M 0.03M 0.19M 0.06M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.82300M -2.84800M 1.84M 3.23M 1.24M
Stock based compensation 0.35M 0.16M 0.17M 0.11M 0.07M
Other non cash items 0.48M 0.56M 0.19M 0.01M 0.00500M
Free cash flow -3.08800M -5.00000M 1.48M 3.89M 0.97M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COG
Cambridge Cognition Holdings Plc		 0.50 1.23% 41.00 - 14.16 2.19 8.48 2.30 100.23
CRW
Craneware Plc		 -5.0 0.34% 1470.00 37.07 12.84 2.55 2.16 3.42 11.56
RENX
Renalytix AI plc		 0.05 1.61% 3.15 - - 6.44 8.06 3.81 -0.2835
FDBK
Feedback PLC		 -0.185 1.40% 13.06 - - 9.56 0.89 2.29 -0.8995
TRLS
Trellus Health plc		 -0.037 7.05% 0.49 3.25 - 275.30 0.30 19.80 1.06

Reports Covered

Stock Research & News

View All

Profile

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Cambridge Cognition Holdings Plc

Tunbridge Court, Cambridge, United Kingdom, CB25 9TU

Key Executives

Name Title Year Born
Dr. Matthew Stork CEO & Director NA
Mr. John Hammond Co-Founder NA
Mr. Stephen Daniel Symonds CFO & Exec. Director 1975
Mr. Nick Taptiklis Head of Technology Strategy NA
Ms. Francesca Cormack Ph.D. Chief Scientist NA
Mr. Simon Merritt Marketing and Communications Director NA
Dr. Lisa Elizabeth Nolan Ph.D. VP Bus. Devel. 1962
Ms. Nicky Ackerley Global HR Director NA
Prof. Trevor Robbins Sr. Consultant NA
Prof. Barbara Sahakian FMedSci, FBPsS Sr. Consultant NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.